Supriya Lifescience Reports Q1 2026 Unaudited Financial Results; Revenue Reaches 1,897.47 R Million
Supriya Lifescience Limited announced its unaudited financial results for the quarter ended June 30, 2026. The company's Board of Directors reviewed and approved these outcomes at a meeting held on August 13, 2026.The Financial Statements reflect operational updates, including the status of material dispatched, which was intercepted and detained by Customs as of June 30, 2026. Despite this event, the transaction was recorded as a sale in the company's books. The unaudited results were reviewed by the Audit Committee and subsequently approved by the Board of Directors.The financial performance metrics for the quarter ended June 30...